Oslo - Delayed Quote NOK
BerGenBio ASA (BGBIO.OL)
1.7540
-0.0640
(-3.52%)
As of 12:03:05 PM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-153,242
-153,242
-225,101
-288,231
-303,340
Investing Cash Flow
3,688
3,688
3,055
3,248
3,130
Financing Cash Flow
129,610
129,610
224,884
2,904
15,995
End Cash Position
140,155
140,155
156,421
150,803
436,646
Issuance of Capital Stock
138,874
138,874
262,048
3,218
16,629
Free Cash Flow
-153,242
-153,242
-225,101
-288,231
-303,340
12/31/2021 - 4/7/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SOFTX.OL SoftOx Solutions AS
0.0656
+2.83%
MVIR.ST Medivir AB (publ)
1.6300
+1.87%
LYTIX.OL Lytix Biopharma AS
5.18
-3.72%
ONCO.ST Oncopeptides AB (publ)
1.9240
-1.13%
HNSA.ST Hansa Biopharma AB (publ)
25.04
+12.29%
VYNE VYNE Therapeutics Inc.
1.8400
-1.08%
GUBRA.CO Gubra A/S
351.40
-2.71%
IBO Impact BioMedical Inc.
0.4258
+0.34%
ARCT Arcturus Therapeutics Holdings Inc.
12.65
+3.94%
CAPR Capricor Therapeutics, Inc.
13.15
-5.33%